MedPath

Testosterone Propionate

Generic Name
Testosterone Propionate
Drug Type
Small Molecule
Chemical Formula
C22H32O3
CAS Number
57-85-2
Unique Ingredient Identifier
WI93Z9138A
Background

Testosterone propionate is a slower-releasing anabolic steroid with a short half-life. It is a synthetic androstane steroid derivative of testosterone in the form of 17β propionate ester of testosterone. Testosterone propionate was developed initially by Watson labs, and FDA approved on February 5, 1974. Currently, this drug has been discontinued in humans, but the vet application is still available as an OTC.

Indication

1.原发性或继发性男性性功能低减;2.绝经后女性晚期乳腺癌的姑息性治疗;男性青春期发育迟缓。

Associated Conditions
Breast Cancer, Puberty, Delayed, Testosterone Deficiency, Hematomas

Hormones and Decision Making

Phase 4
Completed
Conditions
Dyssocial Behavior
Interventions
Drug: 0.5% cholorbutanol, saline
First Posted Date
2021-04-29
Last Posted Date
2021-04-29
Lead Sponsor
University of Texas at Austin
Target Recruit Count
30
Registration Number
NCT04865562
Locations
🇺🇸

Robert Josephs, Austin, Texas, United States

Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.

Phase 1
Suspended
Conditions
Vaginitis
Dyspareunia
Breast Neoplasms
Interventions
First Posted Date
2010-05-13
Last Posted Date
2010-05-13
Lead Sponsor
University of Vermont
Target Recruit Count
30
Registration Number
NCT01122342
Locations
🇺🇸

Fletcher Allen Health Care, University of Vermont, Burlington, Vermont, United States

🇺🇸

Memorial Hospital of Rhode Island,, Pawtucket, Rhode Island, United States

Testosterone Replacement in Middle-Aged Hypogonadal Men With Dysthymia: Parallel Group, Double Blind Randomized Trial

Phase 4
Conditions
Dysthymic Disorder
First Posted Date
2005-12-01
Last Posted Date
2006-10-04
Lead Sponsor
Sheba Medical Center
Registration Number
NCT00260390
Locations
🇮🇱

Sheba Medical Center, Psychiatric out patient clinical unit, Tel Hashomer, Israel

© Copyright 2025. All Rights Reserved by MedPath